Cairo – Mubasher: The Egyptian Exchange’s (EGX) indices went up in the fourth quarter of 2017 and the market capitalisation increased by EGP 76.3 billion on the back of listing shares of Ibnsina Pharma and Al Tawfeek for Financial Lease (AT Lease).
The benchmark EGX30 index jumped 8.14% to 15,019.14 points during Q4-17, compared to 13,888.51 points in the previous quarter.
The EGX’s market capitalisation rose by EGP 76.3 billion to EGP 824.9 billion in Q4-17.
The small and medium-sized enterprises index EGX70 gained 7%, or 54.13 points, to 827.66 points in Q4-17, from 773.53 points in the quarter before.
The broader EGX100 index levelled up 14.4%, reaching 1,971.76 points in Q4-17, compared to 1,723.81 points in Q3-17.
The equal-weight EGX50 index grew 11% to hit 2,569.04 points in Q4-17, from 2,313.32 points in the earlier quarter.
In Q4-17, foreign and Arab investors were net buyers with EGP 2.7 billion and EGP 1.8 billion, respectively, while Egyptians were net sellers with EGP 4.5 billion, according to MubasherTrade PRO’s data.
Egyptian investors acquired 72.6% of the EGX’s trading, followed by foreign traders with 17.7%, while the Arabs acquired 9.7% during Q4-17.
The individual investors were net sellers with EGP 3.7 billion to acquire 61.2% of the bourse’s trading, while the institutional investors were net buyers with EGP 3.7 billion to take over 38.8% of the EGX’s trading.
In December 2017, the benchmark EGX30 index went up 3% to 15,019.14 points, compared to 14,582.22 points in November.
The bourse’s market capitalisation added EGP 10.79 billion, hitting EGP 824.9 billion during December.
